Pharmaceutical and biotechnology company Pfizer Inc. missed out on revenue estimates in its latest quarterly revenue published Aug. 1 amid declining sales of its COVID-19 products. The U.S. drugmaker reported second-quarter revenue of $12.7 billion, missing out on analysts’ estimates of ...